Recent clashes between practitioners of Chinese and Western medicine have once again rekindled the usually dormant animosity that marks the uneasy coexistence of the two medical systems.
At the center of the debate is a figure whose personal story exemplifies the medical tug of war that has become increasingly heated since the ban on aristolochic acid, an herbal drug commonly used in Chinese medicine, on Nov 4.
Wang Yun-kai (
PHOTO: GEORGE TSORNG, TAIPEI TIMES
"I began taking the drug in October of 2001 because I was always tired, and I realized that the aristolochic acid in the drug had damaged my kidneys by July of 2002," Wang stated.
When Wang gave voice to his personal experience at a Veterans' General Hospital workshop on herbal poisoning, he received both applause and accusations.
Doctors representing the National Chinese Medicine Association accused him of inaccurately portraying the effects of aristolochic acid, while others welcomed Wang's support in the effort to ban the acid.
Firestorm
Wang's testimony, along with the ban on aristolochic acid, sparked a chain of subsequent attacks on both Chinese and Western medicine in the following week, culminating with Veterans' General Hospital doctor Wu Ming-ling (
The said events highlight the politics that move beneath the surface of medical treatment. "Western medicine has a history of about 200 years, which is a small slice of Chinese medical history," Wang said, "Nevertheless, Western medicine more or less dominates the field."
Cheng Ping-sheng (
Deng Jou-fan (
"They do not want doctors of Western medicine to research Chinese drugs, but when the use of Chinese medicine leads to an emergency situation, patients come to us," Deng protested.
Commenting on the two different points of view, Chairman of the Department of Health's (DOH) Committee on Chinese Medicine and Pharmacy Lin I-hsin (
Holistic approach
"Chinese medicine is often accused of being unscientific because it does not offer numerical evidence," Lin acknowledged.
"However, the fundamental theory behind Chinese medicine is that the human body is like a small universe in and of itself, and treatment therefore focuses on the whole. Western medicine on the other hand was established under the microscope, and generally focuses on the individual parts that make up the whole," Lin said.
"As a result, the nature of the drugs used by Chinese and Western-medicine practitioners is also quite dissimilar. While Western drugs generally only have one primary chemical component, Chinese drugs are usually a combination of several different substances, underscoring a holistic approach to treatment," Lin said.
Lin touched on one of the key points raised by Chinese-medicine practitioners in response to charges that Chinese drugs are unsafe -- does the Western scientific method used to determine the harmful effects of a Chinese drug take into account how Chinese medicine is practiced?
"All medicine is poisonous to some degree. It is how the medicine is used that determines its benefit," Wang emphasized.
Chen Yi-tai (
`Unscientific'
As expected, Western medicine doctors disagreed. According to Deng, it is the responsibility of the Chinese-medicine doctors to clearly lay out how a drug should be used, for how long, and the possible side effects. "Chinese medicine needs to become more scientific if it is to be safe," he said.
The accusation of being unscientific is ironically the same complaint that Chinese-medicine doctors have raised against Western-medicine doctors. Wu's blanket statement that Chinese drugs can lead to liver damage was disputed by the National Union Association of Chinese Medical Doctors specifically because they felt it was not an evidence-based, thoroughly scientific conclusion.
Wu and other Western-medicine doctors were accused of prematurely calling Chinese drugs unsafe before enough bedside diagnostic tests had been performed, unfairly tarnishing Chinese medicine.
However, there are also commercial motives involved, fueling the race to be more scientific. "The reason why Western medicine has the upper hand in the playing field is simply because there are more Western pharmaceutical companies. A lot of times doctors are merely dispensers of medicine," Wang said.
Deng also admitted that science sells, explaining that consumers would be unwilling to use Chinese medicine if it remained unable to develop an appropriate technology of medicinal management. "Before Western drugs are sold, there is a standard process for determining appropriate usage. The drugs are clearly labeled so that consumers know what they are getting. Chinese drugs will be unacceptable in today's society if they cannot cater to the needs of consumers," said Deng.
Government role is important
Meanwhile, it becomes clear that the government's management of Chinese drugs is crucial to both the pressure to become more scientific and the commercial incentives that underlie it.
"The DOH's control of Chinese drugs is too loose. They do not want to upset Good Manufacturing Practice (GMP) certified companies, but we need stricter management," Wang said.
According to Lin, the DOH established a medical center in Chang Gung Memorial hospita in 2001 to monitor Chinese medicine. "The center brings together Chinese-medicine doctors, pharmacognosy experts, epidemiologists, and poison control experts in an effort to build an organized database of information on Chinese drug poisoning," Lin said.
Lin concluded that Chinese and Western medicine both have advantages and disadvantages, pointing out that both are covered by the National Health Insurance; patients should choose appropriate treatment methods depending on their illness.
RESOLUTIONS DEBATE: Taiwan’s allies said that UN and WHA resolutions cited by China and other nations ‘do not determine Taiwan’s participation in WHO activities’ A proposal to invite Taiwan to this year’s World Health Assembly (WHA) was rejected on Monday, resulting in Taipei’s absence from the annual meeting for a ninth consecutive year, although partners spoke up for Taiwan’s participation at the first day of the meeting. The first agenda item after the opening was a “two-on-two debate” on a proposal to invite Taiwan to participate at the WHA as an observer. Similar to previous years, two countries made statements in favor of the proposal, while two others expressed their opposition. Philippine Secretary of Health Teodoro Herbosa, president of the 78th WHA, accepted the WHA General Committee’s
Palauan President Surangel Whipps Jr arrived in Taiwan last night to kick off his first visit to the country since beginning his second term earlier this year. After arriving at Taoyuan International Airport at around 6:30 pm, Whipps and his delegation were welcomed by Minister of Foreign Affairs Lin Chia-lung (林佳龍). Speaking to gathered media, the Palauan leader said he was excited and honored to be back in Taiwan on his first state visit to Taiwan since he was sworn in this January. Among those traveling with Whipps is Minister of State Gustav N. Aitaro, Public Infrastructure
Premier Cho Jung-tai (卓榮泰) on Friday laid out the Cabinet’s updated policy agenda and recapped the government’s achievements ahead of the one-year anniversary of President William Lai’s (賴清德) inauguration. Cho said the government had made progress across a range of areas, including rebuilding Hualien, cracking down on fraud, improving pedestrian safety and promoting economic growth. “I hope the public will not have the impression that the Cabinet only asked the legislature to reconsider a bunch of legal amendments,” Cho said, calling the moves “necessary” to protect constitutional governance and the public’s interest. The Cabinet would work toward achieving its “1+7” plan, he said. The
Nvidia founder and CEO Jensen Huang (黃仁勳) hosted a dinner in Taipei last night with key Taiwanese suppliers to celebrate the successful mass production of the company’s new Blackwell AI systems. Speaking to the media earlier yesterday, Huang thanked Nvidia’s Taiwanese partners for their contributions to the company’s ecosystem, while also sharing his plans to meet with Taiwan Semiconductor Manufacturing Co (TSMC) founder Morris Chang (張忠謀). In response to rumors that Nvidia will launch a downgraded Hopper H20 chip for China in July, Huang dismissed the reports, saying, “That is not true.” He clarified that there
RSS